LTZ Therapeutics

0 followers

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.


Org chart

Robert Li
Founder, CEO
Collapse
Kathy Zeng
HR Manager
Dr. Vivian Tian
SVP, Business Development and Licensing
Danielle Talbot
Director, Clinical Biomarkers
Martin Treder
Co-founding CSO and member of the board
Sherry Unabia
Director Clinical Operations

Teams

This company has no teams yet